Skip to main content

User account menu

Show — User account menu Hide — User account menu
  • Log in
Home
Amarin

Breadcrumb

  1. Home
  2. News
  3. New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients
Submitted by amarin on Sun, 11/09/2025 - 21:15
Home
News
New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinf…
ID Reference
25131

Tags

  • General Releases
Page Tags
Global
News / Press Release
News & Media
News title
New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients

Search

API search

Title (indexed field):
Title (indexed field):
Title (indexed field):
Title (indexed field):
Title (indexed field): t1

Footer menu

Show — Footer menu Hide — Footer menu
  • Contact
Powered by Drupal